MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with E

Eplerenone

Eplerenone 25mg tablets

No stability information

Stability notes for Eplerenone 25mg tablets

There are no stability notes for this medicine.

Suppliers (15) of Eplerenone 25mg tablets
Eplerenone 25mg tablets (A A H Pharmaceuticals Ltd)
Eplerenone 25mg tablets (Accord-UK Ltd)
Eplerenone 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Eplerenone 25mg tablets (Amarox Ltd)
Eplerenone 25mg tablets (Aspire Pharma Ltd)
Eplerenone 25mg tablets (Consilient Health Ltd)
Eplerenone 25mg tablets (Crescent Pharma Ltd)
Eplerenone 25mg tablets (HBS Healthcare Ltd)
Eplerenone 25mg tablets (Krka UK Ltd)
Eplerenone 25mg tablets (Medihealth (Northern) Ltd)
Eplerenone 25mg tablets (MSN Laboratories Europe Ltd)
Eplerenone 25mg tablets (Zentiva Pharma UK Ltd)
Eplerenone 25mg tablets (Zydus Pharmaceuticals UK Ltd)
Inspra 25mg tablets (Sigma Pharmaceuticals Plc)
Inspra 25mg tablets (Viatris UK Healthcare Ltd)

Eplerenone 50mg tablets

No stability information

Stability notes for Eplerenone 50mg tablets

There are no stability notes for this medicine.

Suppliers (15) of Eplerenone 50mg tablets
Eplerenone 50mg tablets (A A H Pharmaceuticals Ltd)
Eplerenone 50mg tablets (Accord-UK Ltd)
Eplerenone 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Eplerenone 50mg tablets (Amarox Ltd)
Eplerenone 50mg tablets (Aspire Pharma Ltd)
Eplerenone 50mg tablets (Consilient Health Ltd)
Eplerenone 50mg tablets (Crescent Pharma Ltd)
Eplerenone 50mg tablets (HBS Healthcare Ltd)
Eplerenone 50mg tablets (Krka UK Ltd)
Eplerenone 50mg tablets (Medihealth (Northern) Ltd)
Eplerenone 50mg tablets (MSN Laboratories Europe Ltd)
Eplerenone 50mg tablets (Viatris UK Healthcare Ltd)
Eplerenone 50mg tablets (Zentiva Pharma UK Ltd)
Inspra 50mg tablets (Sigma Pharmaceuticals Plc)
Inspra 50mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.